TABLE 1.
Gene | Group | Acrophase (h) | Mesor | Amplitude | P value |
---|---|---|---|---|---|
Clock | Cont | 0.59 | 0.61 | 0.21 | <0.01 |
HFD | ns | ||||
MelHF | 6.57 | 0.41 | 0.16 | <0.05 | |
Cry1 | Cont | 1.90 | 0.85 | 0.37 | <0.01 |
HFD | 1.12 | 0.82 | 0.27 | <0.01 | |
MelHF | 0.54 | 0.71 | 0.27 | <0.01 | |
Cry2 | Cont | 20.42 | 0.97 | 0.56 | <0.01 |
HFD | 20.63 | 0.83 | 0.40 | <0.01 | |
MelHF | 17.84 | 0.64 | 0.30 | <0.01 | |
Per1 | Cont | 19.60 | 2.88 | 4.20 | <0.01 |
HFD | 19.30 | 2.44 | 3.30 | <0.01 | |
MelHF | 18.38 | 1.90 | 2.37 | <0.01 | |
Per2 | Cont | 22.27 | 0.60 | 0.5 | <0.01 |
HFD | 21.91 | 0.44 | 0.38 | <0.01 | |
MelHF | 20.89 | 0.30 | 0.25 | <0.01 |
The rhythmicity was assessed by cosinor analysis, and P < 0.05 indicated a significant rhythm; ns means the difference was nonsignificant (P > 0.05). The model can be written according to the equation f(x) = A + B cos [2 π(x + C)/24], with f(x) indicating relative expression levels of target genes, x indicating the time of sampling (h), A indicating the mean value of the cosine curve (midline estimating statistic of rhythm [mesor]), B indicating the amplitude of the curve (half of the sinusoid), and C indicating the acrophase (h).